HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatal fulminant hepatitis associated with bromfenac use.

AbstractOBJECTIVE:
To report a case of fulminant hepatic failure associated with the use of bromfenac, a new analog of the phenyl acetate class of nonsteroidal antiinflammatory drugs.
CASE SUMMARY:
A 60-year-old white woman with liver failure who had no known history of chronic liver disease was transferred to the liver transplant unit for evaluation. For three months preceding her illness, the patient was treated with bromfenac 25 mg po qid for arthritic pain. Prior to the initiation of bromfenac, her liver function test results were normal. Etiologic evaluation at presentation was unremarkable. The patient's condition continued to deteriorate, with the development of hepatic encephalopathy and worsening liver function test results while awaiting liver transplantation. Progressive hepatic and renal dysfunction along with respiratory decompensation ensued, and the patient died 48 days after initial presentation.
CONCLUSIONS:
Fulminant hepatic failure associated with the prolonged use of bromfenac appears to be an idiosyncratic response consistent with experience with other agents of its class. This case along with other cases of serious hepatotoxicity associated with the use of this agent ultimately resulted in bromfenac's removal from the market.
AuthorsJ M Rabkin, M J Smith, S L Orloff, C L Corless, P Stenzel, A J Olyaei
JournalThe Annals of pharmacotherapy (Ann Pharmacother) Vol. 33 Issue 9 Pg. 945-7 (Sep 1999) ISSN: 1060-0280 [Print] United States
PMID10492497 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzophenones
  • Bromobenzenes
  • bromfenac
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (adverse effects, therapeutic use)
  • Arthritis (complications)
  • Benzophenones (adverse effects, therapeutic use)
  • Bromobenzenes (adverse effects, therapeutic use)
  • Fatal Outcome
  • Female
  • Hepatic Encephalopathy (chemically induced)
  • Humans
  • Liver (drug effects, pathology)
  • Middle Aged
  • Pain (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: